Hunan Hansen Pharmaceutical Co Ltd (002412)

Currency in CNY
6.85
+0.07(+1.03%)
Closed·

002412 Financial Summary

Key Ratios

P/E Ratio19.57
Price/Book1.55
Debt / Equity3.79%
Return on Equity8.21%
Dividend Yield0.00%
EBITDA276.74M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2022
01/01
2023
01/01
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.02 / --
Revenue / Forecast
269.29M / --
EPS Revisions
Last 90 days

FAQ

What were Hansen Pharm A's earnings for the latest quarter?

The Hansen Pharm A EPS (TTM) is 0.34. Hansen Pharm A reported sales of 269.29, net income of 11.26, and EPS of 0.02 for the latest quarter.

What was Hansen Pharm A's net income for the latest quarter?

Hansen Pharm A's net income for the latest quarter was 11.26.

How did Hansen Pharm A's performance compare year-over-year in the latest quarter?

The company's revenue moved from 310.49 in the previous quarter to 269.29 in the latest quarter, and net income moved from 89.49 to 11.26 compared to the previous quarter.

What is Hansen Pharm A's net profit margin on a TTM basis?

Hansen Pharm A's trailing twelve months (TTM) net profit margin is 21.93%.

How does Hansen Pharm A's debt to equity ratio compare to industry standards?

Hansen Pharm A's total debt-to-equity ratio is 3.79%.

What is Hansen Pharm A's return on investment on a TTM basis?

Hansen Pharm A's trailing twelve months (TTM) return on investment (ROI) is 8.21%.

Did Hansen Pharm A gain or lose cash last quarter?

In the latest quarter, Hansen Pharm A's net change in cash was -39.73 million.

What were Hansen Pharm A's total assets and liabilities in the latest quarter?

As of the latest quarter, Hansen Pharm A reported total assets of 2,546.11 million and total liabilities of 327.63 million.

How has Hansen Pharm A's total revenue grown this year?

Hansen Pharm A's total revenue was 310.49 in the previous quarter and 269.29 in the latest quarter.

What is Hansen Pharm A's gross margin on a TTM basis?

Hansen Pharm A's trailing twelve months (TTM) gross margin is 75.69%.

What was Hansen Pharm A's revenue per share for the latest quarter?

Hansen Pharm A's revenue per share for the latest quarter was 7.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.